NIHR BioResource: Opportunity for next generation sequencing support
The NIHR BioResource for Rare Diseases is an integral part of the NIHR BioResource (nihrbioresource.org.uk) and has been awarded NIHR funding for the clinical application of next generation sequencing techniques (NGST). This funding will be used to deliver ~5,000 exomes per year for the next 3-5 years and applications to use this facility are invited from NIHR BRC researchers.
New director of research post for Imperial Academic Health Science Centre
Professor Jonathan Weber has been appointed to the new combined role across Imperial College Healthcare NHS Trust and Imperial College London
Imaging Theme Pilot Project Competition
The NIHR Imperial BRC Imaging Theme has launched a call for pilot phase II projects that seek to accelerate clinical research through the use of enabling innovative imaging technologies.
NIHR Imperial BRC Public Showcase Event 2012
On November 1 2012, the National Institute for Health Research (NIHR) Imperial BRC opened its doors to patients, healthcare professionals, A-Level Biology students and members of the local community of North West London to enable them to explore the variety and breadth of translational research being undertaken at the NIHR Imperial BRC.
NIHR Imperial BRC Researchers honoured by the Academy of Medical Sciences
Four NIHR Imperial BRC researchers have been commended as distinguished scientists by the Academy of Medical Sciences. Election to the Fellowship of the Academy is a mark of recognition to exceptional contributions made to the medical sciences in the form of novel original discovery or sustained contributions to scholarship.
Latest NIHR Funding announcement
April 1st, 2012 marks the beginning of the new NIHR Imperial BRC award. In August 2011, NIHR pledged £112M in funding to the NIHR Imperial Biomedical Research Centre to be used to facilitate the continued development of cutting-edge translational research and healthcare innovations within NIHR Imperial BRC over the course of the next five years.
NIHR/Wellcome Trust Imperial Clinical Research Facility awarded NIHR Funding
On March 1st 2012, it was announced that the NIHR/Wellcome Trust Imperial Clinical Research Facility has been awarded £10.9M in funding from the NIHR, with effect from 1st September 2012. This NIHR investment is to support the translation of scientific advances into benefits for patients through purpose-built Clinical Research Facilities (CRFs).
Therapeutic Primer Fund 2012
NIHR Imperial BRC in partnership with Imperial Innovations sought applications from researchers within Imperial Academic Health Science Centre (AHSC) for funding of projects that support the early stages of drug/therapeutic discovery.
A key part of our vision is to translate biomedical research into practice. For much of this translation we work in partnership. Researchers are supported to translate their ideas and discoveries into new products or treatments through Imperial Innovations.
Low iron levels in the blood may indicate blood clot risk
The BRC-supported study, led by Dr Claire Shovlin and published in Thorax used carefully timed blood samples in patients with the inherited blood vessel disease hereditary haemorrhagic telangiectasia (HHT) to identify a link between low iron levels and potentially lethal blood clots. These findings may lead to changes in routine venous thromboembolism (VTE) risk assessment and prevention strategies.